Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

IMMUNITYBIO, INC. (IBRX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds ImmunityBio, Inc. Investors of Upcoming Deadline Ready to Announce with Confidence?

newsfilecorp.com

IMMUNITYBIO, INC. (IBRX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds ImmunityBio, Inc. Investors of Upcoming Deadline Ready to Announce with Confidence? New York, New York--(Newsfile Corp. - April 7, 2026) - Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds ImmunityBio, Inc. ("ImmunityBio" or the "Company") (NASDAQ: IBRX) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.

Should You Join The ImmunityBio Class Action Lawsuit?

What To Do Next:

If you purchased or acquired ImmunityBio securities, and/or would like to discuss your legal rights and options please visit ImmunityBio, Inc. Shareholder Class Action Lawsuit or contact Investor Relations Manager Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com.

If you wish to serve as lead plaintiff for the Class, you must file papers by May 26, 2026. A lead plaintiff is a representative party acting on other class members' behalf in directing the litigation. Your ability to share in any recovery doesn't require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

About The Lawsuit:

A lawsuit was filed in the United States District Court for the Central District of California on behalf of investors (the "Class") who purchased or acquired the securities of ImmunityBio between January 19, 2026 and March 24, 2026, inclusive, alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its senior officers.

According to the lawsuit, Defendants made misrepresentations concerning the capabilities of ANKTIVA, the Company's lead biologic product.

About Bernstein Liebhard:

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of class actions, the Firm has been named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for sixteen consecutive years.

ATTORNEY ADVERTISING. © 2026 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:

Peter Allocco

Investor Relations Manager

Bernstein Liebhard LLP

https://www.bernlieb.com

(212) 951-2030

pallocco@bernlieb.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/291479

Source: Bernstein Liebhard LLP

Analyst, journalist, or company stakeholder? Sign up to receive news releases by email for Bernstein Liebhard LLP or all companies in the Banking / Financial Services industry.

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Super Micro Computer, Inc. (SMCI)

2026-05-21 9:13 AM EDT

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against ImmunityBio, Inc. (IBRX)

2026-05-21 9:13 AM EDT

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Pinterest, Inc. (PINS)

2026-05-21 9:13 AM EDT

Mar 30, 2026

If PDAC 2026 demonstrated anything, it is that investor demand has clearly returned, but so has competition for attention. With more than 32,000 participants , the highest in the convention’s 94-year history , the Metro Toronto Convention Centre was filled with issuers, investors, and deal makers from around the world. As a media partner of PDAC 2026, TMX Newsfile was on the ground throughout the week, connecting with clients and prospects across the conference. Optimism was evident, with...

Litigation and Regulation

Banking / Financial Services